Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 07, 2023

BUY
$98.98 - $115.74 $210,035 - $245,600
2,122 Added 49.03%
6,450 $746,000
Q2 2023

Jul 18, 2023

BUY
$96.34 - $112.38 $205,011 - $239,144
2,128 Added 96.73%
4,328 $445,000
Q1 2023

May 01, 2023

SELL
$107.32 - $113.5 $1.35 Million - $1.42 Million
-12,537 Reduced 85.07%
2,200 $240,000
Q4 2022

Feb 07, 2023

BUY
$62.39 - $113.8 $919,441 - $1.68 Million
14,737 New
14,737 $1.68 Million
Q2 2022

Aug 04, 2022

SELL
$79.4 - $116.36 $2.39 Million - $3.5 Million
-30,069 Reduced 99.01%
300 $23,000
Q1 2022

Apr 14, 2022

BUY
$86.42 - $109.81 $1.86 Million - $2.36 Million
21,474 Added 241.42%
30,369 $3.2 Million
Q4 2021

Jan 18, 2022

SELL
$98.56 - $119.91 $385,468 - $468,968
-3,911 Reduced 30.54%
8,895 $958,000
Q3 2021

Oct 26, 2021

BUY
$91.91 - $110.37 $1.06 Million - $1.27 Million
11,511 Added 888.88%
12,806 $1.4 Million
Q2 2021

Jul 19, 2021

SELL
$86.24 - $95.92 $934,669 - $1.04 Million
-10,838 Reduced 89.33%
1,295 $121,000
Q4 2020

Jan 21, 2021

BUY
$67.0 - $84.39 $256,811 - $323,466
3,833 Added 46.18%
12,133 $887,000
Q3 2020

Oct 27, 2020

BUY
$55.23 - $79.93 $458,409 - $663,419
8,300 New
8,300 $644,000
Q4 2019

Feb 06, 2020

SELL
$25.43 - $36.67 $76,290 - $110,010
-3,000 Closed
0 $0
Q3 2019

Oct 28, 2019

SELL
$23.0 - $27.97 $23,000 - $27,970
-1,000 Reduced 25.0%
3,000 $81,000
Q2 2019

Aug 09, 2019

BUY
$22.81 - $28.48 $91,240 - $113,920
4,000 New
4,000 $96,000

Others Institutions Holding HZNP

About Horizon Therapeutics Public Ltd Co


  • Ticker HZNP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 230,384,000
  • Description
  • Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. The company operates in two segments, Orphan and Inflammation. Its portfolio comprises 12 medicines ...
More about HZNP
Track This Portfolio

Track Cutler Group LP Portfolio

Follow Cutler Group LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cutler Group LP, based on Form 13F filings with the SEC.

News

Stay updated on Cutler Group LP with notifications on news.